Selected Publications:
Henry D, Glaspy J, Harup R, Mittleman M, Zhou A, Bradley C, Saha G, Bartels P, Leong R, Yu KH: Roxadustat (FG4592; ASP1517; AZD9941) in the Treatment of
Anemia in Patients with Lower Risk Myelodysplastic Syndrome
(LR-MDS) and Low Red Blood Cell (RBC) Transfusion Burden (LTB) American Society of Hematology Meeting : Orlando, FL,2019.
Woodward C, Henry D.: Antiosteolytic Agent Use in Solid Tumor Bone Metastases ESMO-MAP : London,2019.
Byrer E, Kallan M, Chiu T, Scheuba K, Henry D.: A Retrospective Analysis of Venous Thromboembolism Trends in Chemotherapy-Induced Anemia: RBC Transfusion vs Erythrocyte Stimulating Agent Poster, ESCO-MAP : London,2019.
Gascón P, Nagarkar R, Šmakal M, Syrigos KN, Barrios CH, Sánchez JC, Zhang L, Henry DH, Gordon D, Hirsh V, Kubota K, Orlov S, Thomas G, Steinmetz T, Kang JH, Tomita DK, Fleishman AN, Park JK, De Oliveira Brandao C: A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin alfa for Chemotherapy-Induced Anemia in Patients With Advanced Non-Small Cell Lung Cancer Journal of Thoracic Oncology : 2019.
Clifton K, Rich T, Parseghian C, Raymond V, Dasar A, Lima Pereira AA, Willis J, Loree JM, Bauer TM, Kwang Chae Y, Sherrill G, Fanta P, Grothey A, Hendifar A, Henry D, Mahadevan D, Nezami MA, Tan B, Wainberg ZA, Lanman R, Kopetz S, Morris V: Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay JCO Precision Oncology
An American Society of Clinical Oncology Journal : 2019.
Auerbach M, Henry D, Derman R J, Achebe M M, Thomsen L, Glaspy J: A prospective, multi-center, randomized comparison of iron
isomaltoside 1000 versus iron sucrose in patients with iron
deficiency anemia; the FERWON-IDA trial American Journal of Hematology : 2019.
David Henry, Roger von Moos, Jean-Jacques Body, Alex Rider, Jonathan De Courcy, Debajyoti Bhowmik, Francesca Gatta, Guy Hechmati & Yi Qian: Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United States Current Medical Research and Opinion : 2019.
Bryer, E., Henry, D.: A retrospective analysis of venous thromboembolism trends in chemotherapy-induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent (ESA) administration. ASCO : 2019.
David Henry: Roxadustat a new mechanism molecule HIFalpha stabilizer to treat low risk low transfusion burden MDS Blood, American Society of Hematology Meeting, Orlando, Dec 2019 : 2019.
Bryer E, Henry D: Chemotherapy-induced anemia: etiology, pathophysiology, and implications for contemporary practice International Journal of Clinical Transfusion Medicine 2018 : 21-31,2018.